Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice

Wei-Hui Hu,Shing-Hung Mak,Zhong-Yu Zheng,Ying-Jie Xia,Miranda Li Xu,Ran Duan,Tina Ting-Xia Dong,Shao-Ping Li,Chang-Sen Zhan,Xiao-Hui Shang,Karl Wah-Keung Tsim
DOI: https://doi.org/10.3389/fphar.2020.01045
IF: 5.6
2020-07-14
Frontiers in Pharmacology
Abstract:<span><strong>Background:</strong> Shexiang Baoxin Pill (SBP), a formulated traditional Chinese medicine (TCM), has been widely used to treat cardiovascular diseases for years. This herbal mixture has been shown to promote differentiation of cultured neuronal cells. Here, we aimed to investigate the effects of SBP in attenuating cognitive impairment in APP/PS1 transgenic mice.<strong>Methods:</strong> Ethanol and water extracts of SBP, denoted as SBP<sub>EtOH</sub> and SBP<sub>water</sub>, were standardized and applied onto cultured rat pheochromocytoma PC12 cells. The potential effect of SBP<sub>EtOH</sub> extract in attenuating the cognitive impairments in APP/PS1 transgenic mice was shown by following lines of evidence: (i) inhibition of Aβ fibril formation, (ii) suppression of secretions of cytokines, and (iii) improvement of behavioral tests by Morris water maze.<strong>Results:</strong> SBP<sub>water</sub> and SBP<sub>EtOH</sub> inhibited the formation of β-amyloid fibrils and protected the Aβ-induced cytotoxicity in cultured PC12 cells. In APP/PS1 transgenic mice, the treatment of SBP<sub>EtOH</sub> inhibited expressions of NO, NOS, AChE, as well as aggregation of Aβ. Besides, the levels of pro-inflammatory cytokines were suppressed by SBP treatment in the transgenic mice. Importantly, the behavioral tests by Morris Water maze indicated that SBP attenuated cognitive impairments in APP/PS1 transgenic mice.<strong>Conclusion:</strong> The current result has supported the notion that SPB might ameliorate the cognitive impairment through multiple targets, suggesting that SBP could be considered as a promising anti-AD agent.</span>
pharmacology & pharmacy
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve This paper aims to explore and verify the potential efficacy of **Shexiang Baoxin Pill (SBP)** in the treatment of Alzheimer's Disease (AD). Specifically, the study evaluates the effects of SBP on cognitive function improvement in an Alzheimer's disease mouse model (APP/PS1 transgenic mice) through the following aspects: 1. **Inhibition of β-amyloid (Aβ) fibril formation**: By inhibiting the formation of Aβ fibrils, thereby reducing neurotoxicity. 2. **Reduction of cytokine secretion**: Inhibiting the expression of pro-inflammatory cytokines to alleviate inflammatory responses. 3. **Improvement in behavioral tests**: Assessing the cognitive abilities of mice through the Morris water maze test. In summary, the main objective of this paper is to verify whether SBP can improve cognitive impairment in Alzheimer's disease mice through multiple mechanisms and to explore its potential as an anti-Alzheimer's disease drug.